Default Category
-
-
Crescent Petroleum-Dana Gas: Negotiate, Mediate, Arbitrate
Fabbe, Kristin E.; Reinert, Sophus A.; Cisneros, NathanCase HBS-718052-EEconomicsStarting at €8.20
-
The Rise of Populism and Italy's Electoral "Tsunami"
Abdelal, Rawi; Roscini, Dante; Corsi, ElenaCase HBS-719042-EEconomicsThe case explores several reasons behind the rise of populism in Italy and ponders the long-term sustainability of populist governments. Italy's March 2018 elections led to a populist government which included the right-wing League and the anti-establishment 5 Star Movement. To respect their electoral promises, the two parties came up with a budget plan which provided for a public deficit at 2.4%, a figure higher than what the previous administra...Starting at €8.20
-
Can You Say What Your Strategy Is? (Spanish version)
Collis, David J.; Rukstad, Michael G.Article HBS-R0804EStrategyCan you summarize your company's strategy in 35 words or less? Would your colleagues express it the same way? Very few executives can honestly say yes to these simple questions. The thing is, companies with a clear, concise strategy statement - one that employees can easily internalize and use as a guiding light - often turn out to be industry stars. In this article, Harvard Business School's Collis and Rukstad provide a practical guide for craft...Starting at €8.20
-
Veracity Worldwide in Syria: Assessing Political Risk in a Volatile Environment
Musacchio, Aldo; Reinert, Sophus A.Case HBS-712009-EEconomicsThis case explores the dynamic set of political risks raised by a local-partner contract renewal within the context of Syria's unfolding political upheaval. Cambell Technologies, a US-based software firm, was evaluating whether to renew its licensing agreement with Elevate, its Damascus-based distributor. Elevate's strong sales performance and sound management seemed to justify a renewal of its agreement, but the possibility of political change i...Starting at €8.20
-
The Sino-Russian Rapprochement: Energy Relations in a New Era
Abdelal, Rawi; Skalamera, Morena; Tarontsi, SogomonCase HBS-715016-EEconomicsThe United States could enhance or threaten China's energy security but China was unsure of the U.S. intentions. China and the United States were both friends and potential foes. In the meantime, Russia's own ambivalent relationship with the United States and its Western allies worsened. In this context, China and Russia grew closer. Bilateral ties in the energy trade quickly improved: Russian oil exports expanded, while disagreements on the term...Starting at €8.20
-
Bhutan: Governing for Happiness
Reinert, Sophus A.; Humphrey, Thomas; Safran, BenjaminCase HBS-715024-EEconomicsUnique among the world's countries, the Himalayan Kingdom of Bhutan had abandoned the traditional policy goal of increasing Gross Domestic Product (GDP) in favor of pursuing Gross National Happiness (GNH). Famously, Bhutan ranked highly on lists of the happiest countries in spite of a tumultuous history, a low life expectancy, a dismal literacy rate, a small and undiversified economy, and low GDP per capita. Everyone, it seemed, from tourists and...Starting at €8.20
-
Hitachi Rail Limited (B)
Collis, David J.; Kanno, Akiko; Sato, NobuoCase HBS-721365-EStrategyDescribes the strategy and organisation changes made by British executive, Alistair Domer, after he is made head of Hitachi Rail's global business. The company acquires an Italian company, continues to win contracts in the UK, but struggles to bring its gStarting at €5.74
-
Integrating Beam Suntory (B)
Fubini, David G.; Abdelal, Rawi; Lane, DavidCase HBS-421004-ELeadership and People ManagementSupplements (A) case: The spring 2014 acquisition of U.S. alcoholic spirits maker Beam Inc. by Japan's Suntory Holdings vaulted Suntory from 15th to third-largest international spirits company in the world. Yet Suntory had borrowed nearly the entire $16 bStarting at €5.74
-
Takeda Pharmaceutical Company Limited (B)
Collis, David J.; Sato, Nobuo; Kanno, AkikoCase HBS-721374-EStrategyThis case is a follow up to HBS Case No. 721-373, Takeda Pharmaceutical Company Limited (A). Following the events of the previous case, Takeda reached an agreement to acquire Ireland-based Shire Plc. The case follows some of the achievements and challengeStarting at €5.74